Technology | June 18, 2009

FDA Approves St. Jude's Cool Point Irrigation Pump for RF Ablations

June 18, 2009 - St. Jude Medical Inc. said today the FDA approved its Cool Point Irrigation Pump, used in conjunction with St. Jude Medical (SJM) open-irrigated ablation catheters, to supply a continuous flow of saline through the catheter’s inner lumen to cool the ablation electrode for more effective energy delivery.

Designed to enhance physicians’ abilities to perform successful atrial ablations, the new Cool Point Irrigation Pump was developed specifically for use with the company’s IBI-1500T9-CP cardiac ablation generator and family of Therapy Cool Path irrigated catheters.

The Cool Point Irrigation Pump also provides monitoring and safety features designed to give physicians more control over therapy delivery, the company said. Physicians can monitor the total volume of irrigation solution delivered through an easy-to-read display.

The pump’s proprietary tubing includes an in-line occlusion detector, which monitors flow pressure between the pump and the catheter tip, providing an alert if flow pressure increases substantially relative to the flow rate. In addition, the pump has redundant bubble detectors, each designed to detect bubbles as small as 2 microliters.

For more information: www.sjm.com


Related Content

News

Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...

Home September 08, 2026
Home
News

Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...

Home September 02, 2026
Home
News

July 8, 2026 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy ...

Home July 08, 2026
Home
News

May 21, 2026 — Adagio Medical Holdings, a provider of catheter ablation technologies for treating cardiac arrhythmias ...

Home May 22, 2026
Home
News

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...

Home April 29, 2026
Home
News

April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...

Home April 27, 2026
Home
News

April 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation ...

Home April 27, 2026
Home
News

April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...

Home April 13, 2026
Home
News

In a milestone for Broward Health in Ft. Lauderdale, Fla., Jose L. Baez-Escudero, M.D., chief of cardiology and ...

Home March 24, 2026
Home
News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
Subscribe Now